cGKI β 抑制因子

cGKI (cGMP-dependent protein kinase type I), also known as PRKG1, lowers the intracellular level of calcium and is important for the relaxation of vascular smooth muscle. cGKI beta Inhibitors offered by Santa Cruz inhibit cGKI beta and, in some cases, other intracellular cGMP and phosphorylation related proteins. View detailed cGKI beta Inhibitor specifications, including cGKI beta Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.

indicates a highly recommended product based on customer preference.

产品名称/应用 CAS 产品编号 数量 价格 应用 排名
Rp-8-Br-PET-cyclic GMPS, Sodium Salt
Rp-8-Br-PET-cyclic GMPS, Sodium Salt is a competitive inhibitor of cGMP-dependent protein kinase (cGKI)
172806-20-1 sc-203989
1 µmol
(D) DT-2
(D) DT-2 is A potent, cell permeable and highly selective polypeptide inhibitor of cGMP dependent protein kinase 1α
500 µg

圣克鲁斯生物技术在生物医药研究市场的产品开发方面处于世界领先地位。欢迎 致电我们的免费电话(021) 800-820-8626。 版权 ©, 2007-2021圣克鲁斯生物技术。版权所有。“Santa Cruz Biotechnology”,圣克鲁斯生物技 术的 商标,“Santa Cruz Animal Health”,“San Juan Ranch”,“Supplement of Champions”,San Juan Ranch的商标,“Ultracruz”,“Chemcruz”,“Immunocruz”,“Exactacruz”和“EZ Touch”都是圣克鲁斯生物技术的注册商标。所有的商标都归其各自拥有者所有。